2009
DOI: 10.1111/j.1365-4632.2009.04148.x
|View full text |Cite
|
Sign up to set email alerts
|

Systemic and barrier contraceptives for the dermatologist: a review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
7
0

Year Published

2013
2013
2020
2020

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 8 publications
(7 citation statements)
references
References 166 publications
(274 reference statements)
0
7
0
Order By: Relevance
“…Idiopathic hirsutism is also a serious medical problem. In the case of hormonal disturbances the use of hormonal contraception not only improves the cosmetic situation of the patient but is also necessary to decrease the risks related to hyperandrogenaemia [ 41 ].…”
Section: Who Should Be Treated With Hormonal Contraceptionmentioning
confidence: 99%
“…Idiopathic hirsutism is also a serious medical problem. In the case of hormonal disturbances the use of hormonal contraception not only improves the cosmetic situation of the patient but is also necessary to decrease the risks related to hyperandrogenaemia [ 41 ].…”
Section: Who Should Be Treated With Hormonal Contraceptionmentioning
confidence: 99%
“…Moreover, certain conditions might be worsened by contraceptives such as insulin resistance and is contraindicated in diabetic patients, clotting disorders, and in patients with increased risk of breast cancer. 46 …”
Section: Ovarian Androgen Blockadementioning
confidence: 99%
“…They can be used as monotherapy or in conjunction with benzoyl peroxide, topical retinoic acid, or antibiotics [291]. In the case of hormonal disturbances, the use of hormonal contraception not only improves the cosmetic situation of the patient but is also necessary to decrease the risks related to hyperandrogenemia [286]. According to WHO recommendations, the contraindications to oral contraception are as follows: pregnancy, breast feeding, history of deep venous thrombosis and thromboembolic event, active liver disease, smoking after the age of 35 years, migraine, breast cancer, hypertension, diabetes mellitus with vascular changes, and long-term immobilization [287].…”
Section: Oral Contraceptive Pills (Ocps)mentioning
confidence: 99%